• Charity News

Charity CEOs warn of irreparable damage to UK research

A crisis in charity research funding caused by the COVID-19 pandemic threatens to delay the pace of life saving discoveries. A crisis in charity research funding caused by the COVID-19 pandemic threatens to delay the pace of life saving discoveries.

13 November 2020

• Health & Medicine

Scientists develop next-generation immunotherapy now entering early phase clinical trials

Cancer Research UK scientists have invented a new experimental drug that aims to harness the full power of the body’s own immune system. Cancer Research UK scientists have invented a new experimental drug that aims to harness the full power of the body’s own immune system.

9 November 2020

• Charity News

Cancer Research UK shops in England close during lockdown

Cancer Research UK’s 470 charity shops in England have closed for one month from 5 November, following the announcement of a national lockdown. Cancer Research UK’s 470 charity shops in England have closed for one month from 5 November, following the announcement of a national lockdown.

6 November 2020

• For Supporters

Professor Rebecca Fitzgerald: “We're on the cusp of being able to make more precise cancer diagnoses”

The indefatigable inventor of the Cytosponge-TFF3 detection test, Professor Rebecca Fitzgerald, shares the story of its creation. The indefatigable inventor of the Cytosponge-TFF3 detection test, Professor Rebecca Fitzgerald, shares the story of its creation.

4 November 2020

• For Supporters

Annette and Nick Razey: “Even since my diagnosis, the development of treatments has been astounding”

Long-term supporters Annette and Nick Razey tell us why they decided to make a generous donation through our Challenge Fund. Long-term supporters Annette and Nick Razey tell us why they decided to make a generous donation through our Challenge Fund.

28 October 2020

• Health & Medicine

Immunotherapy drug approved for head and neck cancer

Some people with head and neck cancer will now have access to the immunotherapy drug pembrolizumab (Keytruda) on the NHS in England.    Some people with head and neck cancer will now have access to the immunotherapy drug pembrolizumab (Keytruda) on the NHS in England.   

26 October 2020

• Health & Medicine

GPs say elderly are not seeking help for potential cancer symptoms

53% of GPs say they are concerned that fewer older adults are contacting them with symptoms compared to before the pandemic, according to new findings 53% of GPs say they are concerned that fewer older adults are contacting them with symptoms compared to before the pandemic, according to new findings

23 October 2020

• For Supporters

Avon launches employee e-learning for Breast Cancer Awareness Month

How we’ve worked with Avon to produce an innovative e-learning module to make sure that no one is left in the dark about breast cancer. How we’ve worked with Avon to produce an innovative e-learning module to make sure that no one is left in the dark about breast cancer.

23 October 2020

• Science & Technology

UK could lose up to £7.8 billion of medical research funding because of COVID-19 pandemic 

New figures suggest that the UK could lose up to £7.8 billion of investment in life-saving research by 2027 because of the COVID-19 pandemic. New figures suggest that the UK could lose up to £7.8 billion of investment in life-saving research by 2027 because of the COVID-19 pandemic.

23 October 2020

• Health & Medicine

Creating a shared vision to detect cancer earlier

We're bringing researchers, policy-makers, pharmaceutical companies and the public together to find a way to make early diagnosis better. We're bringing researchers, policy-makers, pharmaceutical companies and the public together to find a way to make early diagnosis better.

15 October 2020

• For Supporters

ScottishPower: 4 steps to £30m

We examine how our eight-year partnership with ScottishPower has seen its employees, customers and suppliers reach an impressive £30m fundraising milestone. We examine how our eight-year partnership with ScottishPower has seen its employees, customers and suppliers reach an impressive £30m fundraising milestone.

15 October 2020

• Science & Technology
• Health & Medicine

Scientists develop new precision medicine approach for pancreatic cancer

Scientists from the University of Glasgow are developing new ways to predict who will respond to drugs targeting damaged DNA in pancreatic cancer.  Scientists from the University of Glasgow are developing new ways to predict who will respond to drugs targeting damaged DNA in pancreatic cancer. 

12 October 2020